Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt–chromium coronary stent system

被引：13

作者：

Ando K. ^{[1
]}

Ishii K. ^{[2
]}

Tada E. ^{[2
]}

Kataoka K. ^{[3
]}

Hirohata A. ^{[4
]}

Goto K. ^{[5
]}

Kobayashi K. ^{[6
]}

Tsutsui H. ^{[7
]}

Nakahama M. ^{[8
]}

Nakashima H. ^{[9
]}

Uchikawa S. ^{[10
]}

Kanda J. ^{[11
]}

Yasuda S. ^{[12
]}

Yajima J. ^{[13
]}

Kitabayashi H. ^{[14
]}

Sakurai S. ^{[15
]}

Nakanishi K. ^{[16
]}

Inoue N. ^{[17
]}

Noike H. ^{[18
]}

Hasebe T. ^{[19
]}

Sato T. ^{[20
]}

Yamasaki M. ^{[21
]}

Kimura T. ^{[22
]}

机构：

[1] Department of Cardiology, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita, Kitakyushu, 802-8555, Fukuoka

[2] Department of Cardiology, Kansai Electric Power Hospital, Osaka

[3] Department of Cardiology, Nabari City Hospital, Nabari

[4] Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama

[5] Department of Cardiovascular Medicine, Fukuyama Cardiovascular Hospital, Fukuyama

[6] Department of Cardiovascular Medicine, Ageo Central General Hospital, Ageo

[7] Department of Cardiovascular Medicine, Suwa Red Cross Hospital, Suwa

[8] Department of Cardiology, Fukuyama City Hospital, Fukuyama

[9] Department of Cardiovascular Medicine, National Hospital Organization Kagoshima Medical Center, Kagoshima

[10] Department of Cardiology, Azumino Red Cross Hospital, Azumino

[11] Department of Cardiovascular Medicine, Asahi General Hospital, Asahi

[12] Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka

[13] The Cardiovascular Institute, Tokyo

[14] Department of Cardiovascular Medicine, Ina Central Hospital, Ina

[15] Department of Cardiology, Marunouchi Hospital, Tokyo

[16] Department of Internal Medicine, Ibaraki Seinan Medical Center Hospital, Sashima

[17] Department of Cardiology, Sendai Kousei Hospital, Sendai

[18] Department of Cardiovascular Medicine, Toho University Medical Center Sakura Hospital, Sakura

[19] Department of Radiology, Tokai University Hachioji Hospital, Hachioji

[20] Department of Cardiovascular Medicine, Japanese Red Cross Okayama Hospital, Okayama

[21] Department of Cardiology, NTT Medical Center Tokyo, Tokyo

[22] Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto

来源：

Cardiovascular Intervention and Therapeutics | 2017年 / 32卷 / 3期

基金：

日本学术振兴会;

关键词：

Coronary stent; Diamond-like carbon (DLC); Restenosis; Thrombosis;

D O I：

10.1007/s12928-016-0407-z

中图分类号：

学科分类号：

摘要：

The purpose of this multi-center, non-randomized, and open-label clinical trial was to determine the non-inferiority of diamond-like carbon (DLC)-coated cobalt–chromium coronary stent, the MOMO DLC coronary stent, relative to commercially available bare-metal stents (MULTI-LINK VISION®). Nineteen centers in Japan participated. The study cohort consisted of 99 patients from 19 Japanese centers with single or double native coronary vessel disease with de novo and restenosis lesions who met the study eligibility criteria. This cohort formed the safety analysis set. The efficacy analysis set consisted of 98 patients (one case was excluded for violating the eligibility criteria). The primary endpoint was target vessel failure (TVF) rate at 9 months after stent placement. Of the 98 efficacy analysis set patients, TVF occurred in 11 patients (11.2 %, 95 % confidence interval 5.7–19.2 %) at 9 months after the index stent implantation. The upper 95 % confidence interval for TVF of the study stent was lower than that previously reported for the commercially available MULTI-LINK VISION® (19.6 %), demonstrating non-inferiority of the study stent to MULTI-LINK VISION®. All the TVF cases were related to target vascular revascularization. None of the cases developed in-stent thrombosis or myocardial infarction. The average in-stent late loss and binary restenosis rate at the 6-month follow-up angiography were 0.69 mm and 10.5 %, respectively, which are lower than the reported values for commercially available bare-metal stents. In conclusion, the current pivotal clinical study evaluating the new MOMO DLC-coated coronary stent suggested its low rates of TVF and angiographic binary restenosis, and small in-stent late loss, although the data were considered preliminary considering the small sample size and single arm study design. © 2016, The Author(s).

引用

页码：225 / 232

页数：7

共 17 条

[1]

Nobuyoshi M., Kimura T., Nosaka H., Mioka S., Ueno K., Yokoi H., Et al., Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients, J Am Coll Cardiol, 12, 3, pp. 616-623, (1988)

[2]

Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Et al., A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease, N Engl J Med, 331, pp. 496-501, (1994)

[3]

Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Et al., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, N Engl J Med, 331, pp. 489-495, (1994)

[4]

Kaiser C., Galatius S., Erne P., Eberli F., Alber H., Rickli H., Et al., Drug-eluting versus bare-metal stents in large coronary arteries, N Engl J Med, 363, pp. 2310-2319, (2010)

[5]

von Birgelen C., Basalus M.W.Z., Tandjung K., van Houwelingen K.G., Stoel M.G., Louwerenburg J.H.W., Et al., A randomized controlled trial in second-generation zotarolimus-eluting resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial, J Am Coll Cardiol, 59, pp. 1350-1361, (2012)

[6]

Gott V.L., Daggett R.L., Young W.P., Development of a carbon-coated, central-hinging, bileaflet valve, Ann Thorac Surg, 48, pp. S28-S30, (1989)

[7]

Hauert R., A review of modified DLC coatings for biological applications, Diam Relat Mater, 12, pp. 583-589, (2003)

[8]

Gutensohn K., Beythien C., Bau J., Fenner T., Grewe P., Koester R., Et al., In vitro analyses of diamond-like carbon coated stents: reduction of metal ion release, platelet activation, and thrombogenicity, Thromb Res, 99, pp. 577-585, (2000)

[9]

Mongrain R., Rodes C.J., Role of shear stress in atherosclerosis and restenosis after coronary stent implantation, Rev Esp Cardiol, 59, 1, pp. 1-4, (2006)

[10]

Kastrati A., Mehilli J., Dirschinger J., Dotzer F., Schuhlen H., Neumann F.J., Et al., Intracoronary stenting and angiographic results:strut thickness effect on restenosis outcome (ISAR-STEREO) trial, Circulation, 103, pp. 2816-2821, (2001)

← 1 2 →